Comparison of MRI-Based Staging and Pathologic Staging for Predicting Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
Katie Merriman, Stephanie A. Harmon, Mason J. Belue, Enis C. Yılmaz, Zoë Blake, Nathan Lay, Tim E. Phelps, Maria J. Merino, Howard L. Parnes, Yan Mee Law, Sandeep Gurram, Bradford J. Wood, Peter L. Choyke, Peter A. Pinto, Barış Türkbey
Abstract
BACKGROUND. Currently most clinical models for predicting biochemical recurrence (BCR) of prostate cancer (PCa) after radical prostatectomy (RP) incorporate staging information from RP specimens, creating a gap in preoperative risk assessment.
Topics & Concepts
MedicineBiochemical recurrenceProstatectomyProstate cancerProstateBiopsyRadiologyCancerUrologyInternal medicineProstate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchCancer, Lipids, and Metabolism